Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
SERUM INTERLEUKIN-6 AS A PREDICATOR OF THE THERAPEUTIC EFFECT AND ADVERSE REACTIONS AFTER TRANSCATHETER ARTERIAL EMBOLIZATION
Autore:
YAMAZAKI H; NISHIMOTO N; OI H; MATSUSHITA M; OGATA A; SHIMA Y; INOUE T; TANG JT; YOSHIZAKI K; KISHIMOTO T; INOUE T;
Indirizzi:
OSAKA UNIV,SCH MED,BIOMED RES CTR,DEPT RADIAT ONCOL,2-2 YAMADAOKA SUITA OSAKA 565 JAPAN OSAKA UNIV,SCH MED,DEPT MED 3 SUITA OSAKA 565 JAPAN OSAKA TEISHIN HOSP,DEPT RADIOL OSAKA JAPAN
Titolo Testata:
Cytokine
fascicolo: 2, volume: 7, anno: 1995,
pagine: 191 - 195
SICI:
1043-4666(1995)7:2<191:SIAAPO>2.0.ZU;2-Z
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACUTE-PHASE PROTEINS; HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION;
Keywords:
INTERLEUKIN 6; TRANSCATHETER ARTERIAL EMBOLIZATION; ANGIOGRAPHY; HEPATOCELLULAR CARCINOMA;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
12
Recensione:
Indirizzi per estratti:
Citazione:
H. Yamazaki et al., "SERUM INTERLEUKIN-6 AS A PREDICATOR OF THE THERAPEUTIC EFFECT AND ADVERSE REACTIONS AFTER TRANSCATHETER ARTERIAL EMBOLIZATION", Cytokine, 7(2), 1995, pp. 191-195

Abstract

To evaluate the value of serum interleukin 6 (sIL-6) for the prediction of therapeutic effect and adverse reaction after transcatheter arterial embolization (TAE), sIL-6 was measured before and after angiography or TAE in 18 patients (three after angiography and 15 after TAE forhepatocellular carcinoma), The three patients with only angiography showed no elevation of sIL-6, while a significant increase was observedafter TAE in the 15 hepatocellular carcinoma patients. The sIL-6 levels of patients with a partial response to TAE were higher at 48-72 hours after the procedure than those of patients with no response (P = 0.045), and the sIL-6 levels of patients who showed adverse reactions were higher at 6-24 h than those of patients without adverse reactions (P = 0.019), sIL-6 level at 48-72 h after TAE reflects the efficacy of TAE, whereas the level at 6-24 h after TAE is related to the severity of adverse reactions, Therefore, sIL-6 may be a useful indicator for prediction of the therapeutic effect of TAE as well as adverse reactions.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/07/20 alle ore 05:33:39